BR112014032579A2 - formulação de fenofibrato - Google Patents
formulação de fenofibratoInfo
- Publication number
- BR112014032579A2 BR112014032579A2 BR112014032579A BR112014032579A BR112014032579A2 BR 112014032579 A2 BR112014032579 A2 BR 112014032579A2 BR 112014032579 A BR112014032579 A BR 112014032579A BR 112014032579 A BR112014032579 A BR 112014032579A BR 112014032579 A2 BR112014032579 A2 BR 112014032579A2
- Authority
- BR
- Brazil
- Prior art keywords
- granules
- fenofibrate
- water
- vivo
- surfactant
- Prior art date
Links
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title abstract 9
- 229960002297 fenofibrate Drugs 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000008187 granular material Substances 0.000 abstract 12
- 229920002678 cellulose Polymers 0.000 abstract 4
- 239000001913 cellulose Substances 0.000 abstract 4
- 238000001727 in vivo Methods 0.000 abstract 4
- 239000004094 surface-active agent Substances 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2012/043971 WO2014003706A1 (en) | 2012-06-25 | 2012-06-25 | Fenofibrate formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014032579A2 true BR112014032579A2 (pt) | 2017-06-27 |
Family
ID=49783663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014032579A BR112014032579A2 (pt) | 2012-06-25 | 2012-06-25 | formulação de fenofibrato |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2863890A4 (enExample) |
| BR (1) | BR112014032579A2 (enExample) |
| CA (1) | CA2877901A1 (enExample) |
| IN (1) | IN2014DN11044A (enExample) |
| WO (1) | WO2014003706A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101925590B1 (ko) * | 2016-08-30 | 2018-12-05 | 대원제약 주식회사 | 개선된 생체이용률을 갖는 페노피브릭산 제제 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2627696B1 (fr) | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US7863331B2 (en) | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| US8586094B2 (en) * | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
| US20080241070A1 (en) * | 2000-09-21 | 2008-10-02 | Elan Pharma International Ltd. | Fenofibrate dosage forms |
| AU2006212609A1 (en) * | 2005-02-10 | 2006-08-17 | Lifecycle Pharma A/S | A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an HMG-CoA reductase inhibitor |
| WO2008014175A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
| FR2940118B1 (fr) * | 2008-12-24 | 2013-08-09 | Ethypharm Sa | Formulation pharmaceutique de fenofibrate nanonise |
| WO2010078429A1 (en) | 2008-12-30 | 2010-07-08 | Impax Laboratories, Inc. | Pharmaceutical dosage forms and methods of manufacturing same |
| US20110217369A1 (en) * | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
-
2012
- 2012-06-25 WO PCT/US2012/043971 patent/WO2014003706A1/en not_active Ceased
- 2012-06-25 IN IN11044DEN2014 patent/IN2014DN11044A/en unknown
- 2012-06-25 EP EP12880074.5A patent/EP2863890A4/en not_active Withdrawn
- 2012-06-25 BR BR112014032579A patent/BR112014032579A2/pt not_active Application Discontinuation
- 2012-06-25 CA CA2877901A patent/CA2877901A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2877901A1 (en) | 2014-01-03 |
| EP2863890A1 (en) | 2015-04-29 |
| IN2014DN11044A (enExample) | 2015-09-25 |
| WO2014003706A1 (en) | 2014-01-03 |
| EP2863890A4 (en) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
| BR112016013201A2 (pt) | administração, uso e aplicações terapêuticas dos sistemas crispr-cas e composições para edição de genoma | |
| TR201906255T4 (tr) | Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar. | |
| BR112013005679A2 (pt) | imidazopiridazinas substituídas | |
| BR112015032340A2 (pt) | composições e artigos para cuidados pessoais | |
| BR112015011244A8 (pt) | análogos de compstatina de reação celular, ação longa ou direcionados e composições e métodos relacionados | |
| BR112017018260A2 (pt) | éteres de celulose esterificados solúveis água tendo um baixo grau de neutralização | |
| BR112015021923A2 (pt) | composições de limpeza contendo uma polieteramina, um polímero removedor de sujeiras e uma carboximetil-celulose | |
| MX2015017771A (es) | Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados. | |
| BR112014026703A2 (pt) | inibidores de dna-pk | |
| MX373352B (es) | Nanopartículas farmacéuticas que muestran la mejora del transporte de la mucosa. | |
| BRPI1102843B8 (pt) | Composições de limpeza límpidas, de baixa irritação com ph relativamente baixo | |
| BR112012032888A2 (pt) | artigos de dose unitária solúveis que compreendem um polímero catiônico | |
| BR112014029185A2 (pt) | nucleosídeos de spirooxetano uracila | |
| EP4614148A3 (en) | Synergistic enhancement of the delivery of nucleic acids via blended formulations | |
| BR112012009487A2 (pt) | formulações de espessante estáveis | |
| BR112018012966A2 (pt) | composições de alimento para animais de estimação | |
| BR112014003139A2 (pt) | musgo de turfa umectável resistente à lixiviação, método de preparação, e método de uso | |
| EP2538779A4 (en) | DIVERSION AND / OR ABUSE MATERIAL COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE | |
| BR112015028278A2 (pt) | processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos | |
| BR112015014065A2 (pt) | éter de celulose esterificado, composição, dispersão sólida, forma de dosagem e invólucro de cápsula | |
| BR112013029920A2 (pt) | composição de cobertura misturável, cobertura de mistura, uso da composição de cobertura misturável e método para preparar a composição de cobertura misturável | |
| BR112017018367A2 (pt) | gelificação de éteres de celulose esterificados | |
| MX340147B (es) | Composiciones farmacéuticas y nutracéuticas del ácido abscísico. | |
| BR112018071602A2 (pt) | compostos de imidazopiridina substituídos como inibidores da indolamina 2,3-dioxigenase e/ou triptofano-2,3-dioxigenase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |